top of page
Jonathan Poyer

Biotech Capital Markets Highlights: Transactions 2X Over 2023





Week Ending August 16th, 2024:


  • Biotech: 4 Transactions (1 IPO, 2 Follow-Ons, and 1 RD) totaling just over $500 Million

  • Med Tech: 1 Transaction (1 Follow-On) totaling just over $50 Million



2024 YTD:


  • 195 Biotech transactions totaling just over $32 Billion v. 2023 YTD: 6 Med Tech transactions just over $16 Billion

  • 9 Med Tech transactions totaling just over $1 Billion v. 2023 YTD: 6 Med Tech transactions totaling just over $400 Million



Private Transactions:


  • Biotech: 170 US Transactions / 68 European Transactions

  • Med Tech: 108 US Transactions / 40 European Transactions



Recent Deals:


  • Crown Laboratories acquired Revance for $924M or $6.66/share

  • Pharmacosmos acquired G1 Therapeutics for $405M or $7.15/share

  • Otsuka Pharmaceutical acquired Jnana Therapeutics $800M

25 views0 comments

Comentários


bottom of page